News in the Life Sciences Industry

- Despite Covid-19, assembly lines in many factories do not stop. Production at Draeger is also in full operation. As a manufacturer of ventilators, the German company's products are currently in high demand. To keep the risk of infection among employees as low as possible, Draeaeger has... Read more ››

MUNICH, May 13, 2020 /PRNewswire/ -- Researchers at the Technical University of Munich (TUM) have developed an innovative x-ray method for lung diagnostics, which they now plan to test in one of its first applications for diagnosis of the respiratory ailment COVID-19 caused by Coronavirus.... Read more ››

LAUSANNE, Switzerland, May 12, 2020 /PRNewswire/ -- Galderma today announced results of DREAM (Dysport Real-world Evaluation and Measured satisfaction study), a clinical study of Dysport®* (abobotulinumtoxinA) for Injection that evaluated patient satisfaction and safety with... Read more ››

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel and BERLIN, May 12, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, announced the acceptance of the binding offer... Read more ››

BRAUNSCHWEIG, Germany, May 12, 2020 /PRNewswire/ -- YUMAB, a German antibody development company, announced today it has identified fully human monoclonal antibodies with neutralizing activity against patient-derived coronavirus strain SARS-CoV2. This milestone was achieved in collaboration with... Read more ››

- Technology provides more tools to fight difficult-to-treat diseases

Collaboration to Use PixCell's Point-of-Care (POC) HemoScreen™ Platform for Patients to Test from Home Their Chemotherapy Treatment Readiness Supported by Interreg Germany-Denmark

SEOUL, South Korea, May 11, 2020 /PRNewswire/ -- Daewoong Pharmaceutical (Daewoong) unveiled for the first time the phase 3 clinical data of Fexuprazan, a novel gastroesophageal reflux disease agent at Digestive Disease Week (DDW) 2020. The abstract of Fexuprazan has been rated in the top 10%... Read more ››

SEOUL, South Korea, May 8, 2020 /PRNewswire/ -- Daewoong Pharmaceutical (Daewoong) unveiled for the first time the phase 3 clinical data of Fexuprazan, a novel gastroesophageal reflux disease agent at Digestive Disease Week (DDW) 2020. The abstract of Fexuprazan has been rated in the top 10%... Read more ››

OSAKA, Japan, and KING OF PRUSSIA, Pa., May 7, 2020 /PRNewswire/ -- The CoVIg-19 Plasma Alliance, an unprecedented plasma industry collaboration recently established to accelerate the development of a plasma-derived hyperimmune globulin therapy for COVID-19, is rapidly building momentum. Its... Read more ››